Nadège Gruel

2.6k citations

37 papers · 1.3k indexed · h-index 19

Cancer Research top 5%
- Breast Cancer Treatment Studies 8
- Cancer Genomics and Diagnostics 7
Oncology top 5%
- Cancer-related Molecular Pathways 6
Pathology and Forensic Medicine top 10%
- Breast Lesions and Carcinomas 4
Molecular Biology
- Glycosylation and Glycoproteins Research 6
Genetics top 10%
Radiology, Nuclear Medicine and Imaging
- Monoclonal and Polyclonal Antibodies Research 8
Biotechnology
- Cancer Research and Treatments 3
Pulmonary and Respiratory Medicine
- Sarcoma Diagnosis and Treatment 3

Co-authors: Olivier Delattre Anne Vincent‐Salomon Gaëlle Pierron Xavier Sastre‐Garau Virginie Raynal Fabien Reyal François Radvanyi Marc‐Henri Stern
Cited by: Cancer Research Oncology Pathology and Forensic Medicine
Journals: PLoS ONE (2 papers)Cancer Cell (1 paper)Cancer Research (3 papers)
Partner nations: France Hungary Morocco

In The Last Decade

Nadège Gruel

37 papers receiving 1.2k citations

Peers

Countries citing papers authored by Nadège Gruel

Since Specialization

Citations

This map shows the geographic impact of Nadège Gruel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nadège Gruel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nadège Gruel more than expected).

Fields of papers citing papers by Nadège Gruel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nadège Gruel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nadège Gruel. The network helps show where Nadège Gruel may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Nadège Gruel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Nadège Gruel Line = papers co-authored together Nadège Gruel links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	CXCR6 expressing T cells: Functions and role in the control of tumors Frontiers in Immunology ·Nesrine Mabrouk,Thi Tran,Ikuan Sam,Ivan Pourmir,Nadège Gruel,Clémence Granier,Joséphine Pineau,Alain Gey,Sebastian Kobold,Elizabeth Fabre,Éric Tartour	2022	45
2	Identification of Tissue of Origin and Guided Therapeutic Applications in Cancers of Unknown Primary Using Deep Learning and RNA Sequencing (TransCUPtomics) Journal of Molecular Diagnostics ·Julien Vibert,Gaëlle Pierron,Camille Benoist,Nadège Gruel,Delphine Guillemot,Anne Vincent‐Salomon,Christophe Le Tourneau,Alain Livartowski,Odette Mariani,Sylvain Baulande,François‐Clément Bidard,Olivier Delattre,Joshua J. Waterfall,Sarah Watson	2021	17
3	A rapid high-performance semi-automated tool to measure total kidney volume from MRI in autosomal dominant polycystic kidney disease European Radiology ·Roslyn Simms,Trushali Doshi,Peter Metherall,Desmon̄d Ryan,P.J. Wright,Nadège Gruel,Maatje D.A. van Gastel,Ron T. Gansevoort,W. B. Tindale,Albert Ong	2019	18
4	First description of a sporadic breast cancer in a woman with BRCA1 germline mutation Oncotarget ·Elsa Curtit,Vanessa Benhamo,Nadège Gruel,Tatiana Popova,Élodie Manié,Paul Cottu,Odette Mariani,Dominique Stoppa‐Lyonnet,Xavier Pivot,Marc‐Henri Stern,Anne Vincent‐Salomon	2015	7
5	Polarity gene alterations in pure invasive micropapillary carcinomas of the breast Breast Cancer Research ·Nadège Gruel,Vanessa Benhamo,Jaydutt Bhalshankar,Tatiana Popova,Paul Fréneaux,Laurent Arnould,Odette Mariani,Marc‐Henri Stern,Virginie Raynal,Xavier Sastre‐Garau,Roman Rouzier,Olivier Delattre,Anne Vincent‐Salomon	2014	34
6	Genomic Instability: A Stronger Prognostic Marker Than Proliferation for Early Stage Luminal Breast Carcinomas PLoS ONE ·Anne Vincent‐Salomon,Vanessa Benhamo,Eléonore Gravier,Guillem Rigaill,Nadège Gruel,Stéphane Robin,Yann De Rycke,Odette Mariani,Gaëlle Pierron,David Gentien,Fabien Reyal,Paul Cottu,Alain Fourquet,Roman Rouzier,Xavier Sastre‐Garau,Olivier Delattre	2013	14
7	Inverted Apical CD24 and Weak EZH2 Expressions Are Phenotypic Characteristics of Pure Invasive Micropapillary Carcinoma of the Breast Nadège Gruel,Aurélie Cédenot,Marion Richardson,Paul Fréneaux,Jaydutt Bhalshankar,Thierry Dubois,Xavier Sastre‐Garau,Olivier Delattre,Anne Vincent‐Salomon	2013	2
8	High Ki67 expression is a risk marker of invasive relapse for classical lobular carcinoma in situ patients The Breast ·Anne Vincent‐Salomon,David Hajage,Alexandre Rouquette,Aurélie Cédenot,Nadège Gruel,S. Alran,Xavier Sastre‐Garau,Brigitte Sigal‐Zafrani,Alain Fourquet,Youlia Kirova	2012	10
9	Lobular invasive carcinoma of the breast is a molecular entity distinct from luminal invasive ductal carcinoma European Journal of Cancer ·Nadège Gruel,Carlo Lucchesi,Virginie Raynal,Manuel Rodrigues,Gaëlle Pierron,Rémi Goudefroye,Paul Cottu,Fabien Reyal,Xavier Sastre‐Garau,Alain Fourquet,Olivier Delattre,Anne Vincent‐Salomon	2010	50
10	High Frequency of TP53 Mutation in BRCA1 and Sporadic Basal-like Carcinomas but not in BRCA1 Luminal Breast Tumors Cancer Research ·Élodie Manié,Anne Vincent‐Salomon,Jacqueline Lehmann‐Che,Gaëlle Pierron,Elisabeth Turpin,Mathilde Warcoin,Nadège Gruel,Ingrid Lebigot,Xavier Sastre‐Garau,Rosette Lidereau,Audrey Remenieras,Jean Feunteun,Olivier Delattre,Hugues de Thé,Dominique Stoppa‐Lyonnet,Marc‐Henri Stern	2009	112
11	Characterization of the Recurrent 8p11-12 Amplicon Identifies PPAPDC1B, a Phosphatase Protein, as a New Therapeutic Target in Breast Cancer Cancer Research ·Isabelle Bernard‐Pierrot,Nadège Gruel,Nicolas Stransky,Anne Vincent‐Salomon,Fabien Reyal,Virginie Raynal,Céline Vallot,Gaëlle Pierron,François Radvanyi,Olivier Delattre	2008	73
12	Integrated Genomic and Transcriptomic Analysis of Ductal Carcinoma In situ of the Breast Clinical Cancer Research ·Anne Vincent‐Salomon,Carlo Lucchesi,Nadège Gruel,Virginie Raynal,Gaëlle Pierron,Rémi Goudefroye,Fabien Reyal,François Radvanyi,Rémy Salmon,Jean Paul Thiery,Xavier Sastre‐Garau,Brigitte Sigal‐Zafrani,Alain Fourquet,Olivier Delattre,(unknown)	2008	114
13	Identification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entity Breast Cancer Research ·Anne Vincent‐Salomon,Nadège Gruel,Carlo Lucchesi,Gaëtan MacGrogan,R. Dendale,Brigitte Sigal‐Zafrani,Michel Longy,Virginie Raynal,Gaëlle Pierron,Isabelle de Mascarel,Taris Corinne,Dominique Stoppa‐Lyonnet,Jean‐Yves Pierga,Rémy Salmon,Xavier Sastre‐Garau,Alain Fourquet,Olivier Delattre,Patricia de Crémoux,Alain Aurias	2007	133
14	Gene expression profiling of 1p35–36 genes in neuroblastoma Oncogene ·Isabelle Janoueix‐Lerosey,Eugene Novikov,Marta Monteiro,Nadège Gruel,Gudrun Schleiermacher,Béatrice Loriod,Catherine Nguyen,Olivier Delattre	2004	45
15	Generation of scFv from a Phage Display Mini-Library Derived from Tumor-Infiltrating B-Cells Humana Press eBooks ·Nadège Gruel,Beatrix Kotlán,Marie Beuzard,Jean‐Luc Teillaud	2003	4
16	PURIFICATION OF SOLUBLE RECOMBINANT HUMAN FcγRII (CD32) Preparative Biochemistry & Biotechnology ·Nadège Gruel,Julius Chapiro,Wolf H. Fridman,Jean‐Luc Teillaud	2001	4
17	Bypassing tumor-specific and bispecific antibodies: triggering of antitumor immunity by expression of anti-FcγR scFv on cancer cell surface Gene Therapy ·Nadège Gruel,Wolf H. Fridman,Jean‐Luc Teillaud	2001	8
18	Restoration of transcriptional activity of p53 mutants in human tumour cells by intracellular expression of anti-p53 single chain Fv fragments Oncogene ·Claude Caron de Fromentel,Nadège Gruel,Corinne Venot,Laurent Debüssche,Emmanuel Conseiller,Christine Dureuil,Jean‐Luc Teillaud,Bruno Tocqué,Laurent Bracco	1999	67
19	Production and Characterization of Mouse Monoclonal Antibodies to Wild-Type and Oncogenic FLI-1 Proteins Hybridoma ·Thomas Melot,Nadège Gruel,Alexandre Doubeikovski,Nicolas Sévenet,Jean‐Luc Teillaud,Olivier Delattre	1997	21
20	A New Set of Monoclonal Antibodies Against Human FcγRII (CD32) and FcγRIII (CD16): Characterization and Use in Various Assays Hybridoma ·Frédéric Vely,Nadège Gruel,Janine Moncuit,Olivier Cochet‐Escartin,Hélène Rouard,SOPHIE DARE,Jérôme Galon,Catherine Sautès‐Fridman,Wolf H. Fridman,Jean‐Luc Teillaud	1997	35

About Nadège Gruel

Nadège Gruel is a scholar working on Cancer Research, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 37 papers that have together received 1.3k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (8 papers), Monoclonal and Polyclonal Antibodies Research (8 papers), Cancer Genomics and Diagnostics (7 papers), Glycosylation and Glycoproteins Research (6 papers), Cancer-related Molecular Pathways (6 papers), Breast Lesions and Carcinomas (4 papers), Cancer Research and Treatments (3 papers) and Sarcoma Diagnosis and Treatment (3 papers). The work is most often cited by research in Cancer Research (477 citations), Oncology (471 citations) and Pathology and Forensic Medicine (196 citations). Nadège Gruel has collaborated with scholars based in France, Hungary and Morocco. Frequent co-authors include Olivier Delattre, Anne Vincent‐Salomon, Gaëlle Pierron, Xavier Sastre‐Garau, Virginie Raynal, Fabien Reyal, François Radvanyi, Marc‐Henri Stern, Jean‐Luc Teillaud and Odette Mariani. Their work appears in journals such as PLoS ONE, Cancer Cell and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact